Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System Post author:Sam Post published:March 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AbbVie Declares Quarterly Dividend February 19, 2017 Astrazeneca Gets Another Boost With FDA Approval of Severe Asthma Drug November 14, 2017 Biotech Bestie Celgene Takes Stake, Inks $1 Billion+ Deal With BeiGene July 5, 2017